Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 155 | 217 | 109 | 90 | 22 |
| Cost of Goods | 52 | 73 | 41 | 61 | 14 |
| Gross Profit | 103 | 144 | 68 | 30 | 8 |
| Operating Expenses | 554 | 1,238 | 346 | 432 | 331 |
| Operating Income | -399 | -1,021 | -237 | -341 | -308 |
| Interest Expense | 143 | 199 | 200 | 200 | 193 |
| Other Income | -51 | 4,452 | 1,013 | -105 | 5,515 |
| Pre-tax Income | -593 | 3,232 | 577 | -646 | 5,014 |
| Net Income Continuous | -593 | 3,232 | 577 | -646 | 5,014 |
| Net Income | $-593 | $3,232 | $577 | $-646 | $5,014 |
| EBITDA(a) | $-312 | $-840 | $-82 | $-191 | $-157 |